Periodontal Disease Treatment Global Market Report 2025

The periodontal disease treatment market size has grown strongly in recent years. It will grow from $1.56 billion in 2024 to $1.68 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to the rising geriatric population, the expansion of dental care infrastructure, the increasing prevalence of chronic and aggressive periodontitis, the heightened risk of periodontal diseases, and the growing number of periodontitis patients with sedentary lifestyles.

The periodontal disease treatment market size is expected to see strong growth in the next few years. It will grow to $2.2 billion in 2029 at a compound annual growth rate (CAGR) of 7%. The growth during the forecast period can be attributed to the increasing demand for better oral hygiene, rising cases of edentulism, a growing number of periodontal therapeutic procedures, higher advertising expenditures, and the expansion of medical and dental tourism in developing countries. Key trends expected during this period include technological innovations, the adoption of advanced treatment technologies, the integration of artificial intelligence in diagnosis, and advancements in periodontal flap surgery.

The increasing prevalence of oral health disorders is expected to drive the growth of the periodontal disease treatment market. These disorders affect the teeth, gums, and mouth, including conditions such as cavities, gum disease, oral infections, and oral cancer. Factors contributing to the rise in oral health disorders include poor oral hygiene, unhealthy diets, tobacco and alcohol use, aging populations, and limited access to dental care. Periodontal disease treatment helps manage and prevent these issues by addressing gum infections, inflammation, and bone loss. For example, in October 2024, the Australian Institute of Health and Welfare (AIHW), a government agency in Australia, reported that poor oral health, including tooth decay, gum disease, and tooth loss, affected a significant number of Australian children and adults, accounting for 4.5% of the overall non-fatal disease burden in 2022. As a result, the increasing incidence of oral health disorders is expected to fuel the growth of the periodontal disease treatment market.

Leading companies in the periodontal disease treatment market are developing innovative solutions such as dental gel to promote bone regeneration, improve treatment accessibility, reduce invasiveness, and provide more effective and patient-friendly alternatives to traditional periodontal treatments. Dental gel is a medicated oral product containing antibacterial, anti-inflammatory, or fluoride agents designed to prevent cavities, reduce gum disease, and relieve oral discomfort. In October 2024, Oral Biolife Inc., a US-based biotechnology company, introduced Ambrilux Dental Gel, a breakthrough treatment aimed at stimulating bone regeneration in cases of periodontal disease. Large animal trials demonstrated promising results, with 100% of Beagle dogs treated showing increased bone growth. This innovation has the potential to transform non-invasive dental care for both humans and companion animals, addressing a critical medical need.

In March 2023, Intermed Inc., a US-based healthcare technology management company, acquired Perio Protect for an undisclosed amount. This acquisition aims to expand Intermed’s dental care solutions by integrating Perio Protect’s periodontal tray treatment technology, strengthening its market position, enhancing its ability to offer comprehensive dental treatments from prevention to restoration, and unlocking new growth opportunities in the U.S. and Canadian markets. Perio Protect, a US-based medical equipment manufacturer, specializes in designing and producing custom trays for the treatment of periodontal disease.

Major players in the periodontal disease treatment market are Bausch Health Companies Inc, DENTSPLY SIRONA Inc., Straumann AG, Sunstar Suisse S.A, NovaBone Products LLC, Nakanishi Inc., Brasseler USA, Geistlich Pharma AG, BIOLASE Inc., Bien-Air Dental, Convergent Dental Inc., Carl Martin GmbH, Karl Schumacher, Yoshida Dental MFG. Co. Ltd., Botiss Biomaterials GmbH, Millennium Dental Technologies Inc., PreXion Inc., AMD Lasers Inc., Steris Healthcare Pvt Ltd, Perio Protect, and Deppeler SA.

North America was the largest region in the periodontal disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in periodontal disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the periodontal disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Periodontal disease treatment encompasses medical procedures and interventions designed to prevent, manage, and reverse the effects of periodontal diseases, which impact the gums and surrounding tooth structures. The primary goal is to reduce inflammation, prevent tooth loss, and enhance overall oral health.

The main types of periodontal disease treatments include gingivitis, chronic periodontal disease, aggressive periodontal disease, and other variations. Gingivitis is characterized by gum swelling, redness, and irritation caused by plaque buildup around the teeth. Treatment options include non-surgical procedures, scaling and root planing, medication, surgical treatments such as flap surgery and bone grafts, and other therapeutic approaches. These treatments are administered through various routes, including oral and injectable methods, and are distributed through hospital pharmacies, retail pharmacies, and other channels. They serve a range of end-users, including hospitals, clinics, dental clinics, dental academic and research institutes, and other healthcare providers.

The periodontal disease treatment market research report is one of a series of new reports that provides periodontal disease treatment market statistics, including the periodontal disease treatment industry global market size, regional shares, competitors with the periodontal disease treatment market share, detailed periodontal disease treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the periodontal disease treatment industry. This periodontal disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The periodontal disease treatment market consists of revenues earned by entities by providing services such as professional dental cleanings, scaling and root planing, antibiotic therapy, surgical interventions for severe cases, laser therapy for gum restoration, and ongoing maintenance to prevent disease progression. The market value includes the value of related goods sold by the service provider or included within the service offering. The periodontal disease treatment market also includes sales of antiseptic mouthwashes, scaling and root planing kits, laser therapy devices, and diagnostic tools & devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values generated by organizations in the specified geography within the market, irrespective of where they are produced. They do not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.